human
coronaviru
gener
classifi
common
cold
pathogen
though
infect
may
also
result
sever
lower
respiratori
tract
diseas
especi
children
patient
underli
diseas
elderli
previous
shown
also
one
import
caus
croup
children
current
manuscript
develop
set
polymerbas
compound
show
promin
anticoronavir
activ
polym
recent
consid
promis
altern
small
molecul
inhibitor
due
intrins
antimicrobi
properti
abil
serv
matric
antimicrobi
compound
antimicrobi
polym
show
antibacteri
properti
antivir
activ
much
less
frequent
cation
modifi
chitosan
deriv
n
chitosan
chlorid
htcc
hydrophobicallymodifi
htcc
shown
potent
inhibitor
replic
furthermor
compound
show
promin
activ
murin
hepat
viru
suggest
broader
anticoronavir
activ
coronavirus
positivestrand
rna
virus
genom
approxim
kb
larg
coronavir
genom
function
divid
two
region
twothird
genom
encod
larg
polyprotein
contain
protein
necessari
rna
replic
onethird
encod
sever
structur
protein
includ
spike
envelop
e
membran
nucleocapsid
n
incorpor
virion
particip
numer
process
eg
viru
bud
nonstructur
accessori
protein
gene
speciesspecif
interspac
structur
gene
viru
particl
envelop
carri
extrud
protein
membran
surfac
provid
virion
typic
crownlik
structur
field
et
al
first
human
coronavirus
describ
alreadi
forti
year
believ
repres
coronavirida
famili
infect
human
associ
rel
mild
respiratori
tract
diseas
bradburn
et
al
hamr
procknow
mcintosh
et
al
tyrrel
byno
chang
took
place
sarscov
emerg
guandong
provinc
china
drosten
et
al
ksiazek
et
al
peiri
et
al
epidem
spread
contain
earli
juli
mostli
quarantin
measur
howev
also
sporad
case
season
peiri
et
al
sudden
outbreak
previous
undescrib
coronaviru
brought
whole
famili
virus
back
limelight
consecut
two
year
two
new
human
coronavirus
identifi
virus
spread
worldwid
link
respiratori
tract
diseas
van
der
hoek
et
al
woo
et
al
gener
classifi
common
cold
viru
sever
lower
respiratori
tract
infect
frequent
observ
young
children
patient
underli
diseas
elderli
arden
et
al
bastien
et
al
b
chiu
et
al
ebihara
et
al
kaiser
et
al
perlman
netland
role
infect
develop
acut
respiratori
diseas
emphas
confirm
infect
associ
acut
see
front
matter
elsevi
bv
right
reserv
http
respiratori
diseas
croup
han
et
al
sung
et
al
van
der
hoek
et
al
wu
et
al
moreov
sporad
fatal
case
report
patient
test
posit
pathogen
could
identifi
bastien
et
al
cabeca
bellei
oosterhof
et
al
consid
preval
indubit
associ
diseas
effect
antivir
treatment
requir
patient
suffer
sever
respiratori
tract
ill
studi
describ
paper
indic
treatment
may
provid
polymer
substanc
polym
intens
studi
potent
antimicrobi
system
due
intrins
antimicrobi
properti
matric
antimicrobi
compound
organ
inorgan
latter
system
howev
requir
diffus
lowmolecularweight
antimicrobi
polymer
matrix
may
toxic
human
bodi
munozbonilla
fernandezgarcia
therefor
polym
possess
antimicrobi
activ
prefer
solut
moreov
polym
usual
show
longterm
activ
particular
interest
among
antimicrobi
polym
polyc
contain
phosphonium
group
kenawi
mahmoud
quaternari
nitrogen
atom
pyridinium
tiller
et
al
imidazolium
anderson
long
ammonium
group
timofeeva
et
al
antimicrobi
polym
contain
halogen
fluorin
caillier
et
al
chlorin
patel
et
al
polym
contain
sulfo
group
zaneveld
et
al
substitut
lowmolecularweight
compound
antibiot
ciprofloxacin
woo
et
al
norfloxacin
yang
santerr
antimicrobi
polym
show
antibacteri
properti
antivir
activ
much
less
frequent
still
difficult
predict
polym
show
antimicrobi
properti
base
structur
therefor
potenti
antimicrobi
activ
verifi
experiment
current
manuscript
cation
modifi
chitosan
deriv
n
chitosan
chlorid
htcc
hydrophobicallymodifi
deriv
hmhtcc
shown
potent
inhibitor
replic
polym
also
show
promin
activ
murin
hepat
viru
betacoronaviru
mhv
suggest
develop
compound
may
repres
novel
class
antivir
compound
treatment
wider
spectrum
coronavir
diseas
chitosan
ch
low
molecular
weight
deacetyl
sigmaaldrich
glycidyltrimethylammonium
chlorid
gtmac
fluka
fluorescein
thioisocyan
isom
fitc
sigmaaldrich
glacial
acet
acid
ch
cooh
pure
pa
chempur
aceton
poch
dmso
poch
methanol
poch
use
receiv
water
distil
twice
deioniz
use
millipor
simplic
system
fourier
transform
infrar
ftir
spectra
obtain
bruker
if
spectromet
nmr
spectra
measur
mixtur
deuterium
oxid
dimethyl
use
bruker
amx
spectromet
uvvi
absorpt
spectra
record
use
diodearray
spectrophotomet
optic
path
quartz
cuvett
element
analysi
perform
use
vario
micro
chn
element
analyz
elementar
gpc
analys
perform
use
water
gpc
system
equip
bank
three
column
pl
aquageloh
tandem
pdari
detector
eluent
nacl
flow
rate
mlmin
sampl
volum
concentr
polym
gl
modif
polym
perform
use
method
previous
describ
kaminski
et
al
briefli
g
chitosan
dispers
ml
distil
water
supplement
ml
acet
acid
ie
vv
solut
water
solut
stir
min
ml
gtmac
ad
obtain
polym
substitut
degre
express
fraction
nh
group
substitut
result
mixtur
heat
incub
h
stir
reflux
condens
suspens
subsequ
centrifug
rpm
min
remov
suspend
unreact
chitosan
product
extract
supernat
via
precipit
aceton
supplement
methanol
subsequ
centrifug
rpm
min
solut
decant
result
pellet
air
dri
dissolv
distil
water
purif
process
repeat
twice
purifi
htcc
dri
vacuum
oven
h
gpc
chromatogram
reveal
singl
peak
data
shown
nmr
spectra
data
shown
signal
appear
ppm
methyl
proton
trimethylammonium
group
confirm
occurr
substitut
reaction
htcc
g
mmol
glucos
unit
dissolv
mixtur
methanol
acet
acid
ph
mmol
ndodecyl
aldehyd
sodium
cyanohydrobor
nacnbh
g
mmol
dissolv
ml
methanol
ad
chitosan
solut
reaction
mixtur
stir
h
sol
form
reaction
complet
sol
precipit
ad
methanoldiethyl
ether
vv
mixtur
white
precipit
wash
use
methanol
diethyl
ether
vacuumdri
structur
obtain
product
verifi
measur
h
nmr
spectra
cd
cood
solut
data
shown
mg
htcc
dissolv
mixtur
ml
distil
water
ml
dmso
five
milligram
fluorescein
thioisocyan
fitc
dissolv
ml
aceton
solut
ad
sampl
contain
htcc
vigor
mix
h
dark
subsequ
fitchtcc
precipit
aceton
isol
centrifug
min
rpm
precipit
wash
aceton
dissolv
water
dialyz
water
day
aceton
water
mixtur
vv
day
freez
dri
degre
substitut
defin
number
fitc
group
per
glucos
group
htcc
found
base
uvvi
spectra
cell
cultur
cell
atcc
macaca
mulatta
kidney
epitheli
cell
line
maintain
minim
essenti
medium
mem
contain
part
hank
mem
part
earl
mem
paa
laboratori
supplement
heatinactiv
fetal
bovin
serum
paa
laboratori
penicillin
uml
streptomycin
lgml
cell
cultur
flask
tpp
co
cell
atcc
human
lung
carcinoma
cell
line
maintain
dulbeccomodifi
eagl
medium
dmem
paa
laboratori
supplement
heatinactiv
fetal
bovin
serum
paa
laboratori
penicillin
uml
streptomycin
lgml
cell
cultur
flask
tpp
co
cell
murin
l
cell
stabli
transfect
nceacam
receptor
maintain
dulbeccomodifi
eagl
medium
dmem
paa
laboratori
supplement
heatinactiv
fetal
bovin
serum
paa
laboratori
penicillin
uml
streptomycin
lgml
lgml
sigmaaldrich
cell
cultur
flask
tpp
co
human
tracheobronchi
epitheli
cell
obtain
airway
specimen
resect
patient
undergo
surgeri
silesian
center
heart
diseas
approv
protocol
studi
approv
bioethic
committe
medic
univers
silesia
katowic
poland
approv
knw
date
written
inform
consent
obtain
patient
primari
cell
expand
plastic
gener
passag
cell
plate
densiti
cell
per
well
permeabl
transwel
insert
support
human
airway
epithelium
hae
cultur
gener
provis
airliquid
interfac
week
form
welldifferenti
polar
cultur
resembl
vivo
pseudostratifi
mucociliari
epithelium
hae
cultur
infect
inocul
infecti
materi
onto
apic
surfac
follow
h
incub
unbound
viru
remov
pb
wash
two
time
hae
cultur
maintain
airliquid
interfac
rest
experi
analyz
replic
h
post
infect
pb
appli
apic
surfac
hae
collect
follow
min
incub
sampl
store
murin
hepat
viru
mhv
strain
stock
gener
infect
cell
respect
cell
lyse
day
day
mhv
postinfect
two
freezethaw
cycl
viruscontain
fluid
aliquot
store
control
mock
infect
cell
cell
prepar
manner
viru
stock
viru
yield
assess
viru
titrat
fulli
confluent
cell
cell
accord
reed
muench
cell
plate
incub
day
day
mhv
cytopath
effect
occurr
score
use
invert
microscop
subsequ
experi
fulli
confluent
cell
expos
mhv
tcid
viru
stock
virus
use
studi
gener
infect
hela
cell
adenoviru
type
rd
cell
echoviru
cell
hmpv
clade
mdck
cell
influenza
h
n
case
cell
lyse
appear
cytopath
effect
two
freezethaw
cycl
viruscontain
fluid
aliquot
store
control
cell
lysat
mockinfect
cell
prepar
manner
viru
stock
experiment
procedur
conduct
previous
describ
pyrc
et
al
stock
sampl
contain
influenza
viru
human
echoviru
human
adenoviru
kindli
provid
marcel
human
metapneumoviru
kindli
provid
oliv
schildgen
viral
nucleic
acid
isol
cell
cultur
supernat
apic
wash
hae
cultur
total
rna
mini
kit
biotechnolog
accord
manufactur
instruct
revers
transcript
carri
high
capac
cdna
revers
transcript
kit
appli
biosystem
accord
manufactur
instruct
mhv
viru
yield
determin
use
realtim
pcr
order
assess
copi
number
mhv
rna
standard
prepar
virus
briefli
mhv
n
gene
amplifi
clone
plasmid
use
instaclon
pcr
clone
kit
thermo
scientif
subsequ
dna
fragment
encod
n
gene
amplifi
use
primer
set
forward
tcg
gcc
tcg
atg
gcc
att
tag
gtg
aca
cta
tag
atg
gct
agt
gta
aat
revers
tcc
gga
ttt
ttt
ttt
ttt
ttt
ttt
ttt
ttt
tta
atg
caa
aac
ctc
gtt
forward
atg
cat
tta
ggt
gac
act
ata
gat
gtc
ttt
tgt
tcc
tgg
gca
revers
tta
cac
att
aga
gtc
atc
ttc
mhv
respect
primer
contain
promot
amplifi
dna
gel
purifi
use
templat
vitro
transcript
use
rna
polymeras
thermo
scientif
reaction
conduct
accord
manufactur
instruct
result
reaction
dnase
treat
dnase
turbo
life
technolog
result
rna
purifi
total
rna
mini
kit
biotechnolog
concentr
assess
use
spectrophotomet
sampl
serial
dilut
use
input
revers
transcript
realtim
pcr
reaction
five
microlit
cdna
amplifi
reaction
mixtur
contain
taqman
univers
pcr
master
mix
amperas
ung
appli
biosystem
specif
probe
label
fam
tamra
nm
primer
nm
rox
use
refer
dye
primer
probe
list
tabl
reaction
monitor
fast
realtim
pcr
machin
appli
biosystem
follow
set
min
min
cycl
min
cell
cultur
plate
describ
cell
viabil
assay
done
use
xtt
cell
viabil
assay
kit
biolog
industri
accord
manufactur
instruct
briefli
medium
discard
cultur
medium
activ
xtt
solut
ad
well
plate
incub
h
follow
step
plate
transfer
colorimet
spectra
max
molecular
devic
signal
measur
k
nm
refer
absorb
measur
neutral
red
uptak
assay
cell
cultur
plate
describ
cell
viabil
assay
done
use
neutral
red
dye
sigmaaldrich
briefli
medium
discard
cell
wash
twice
pb
onehundr
microlit
neutral
red
dye
work
solut
lgml
dye
pb
ad
well
cell
incub
h
follow
step
supernat
discard
cell
wash
twice
steril
pb
lyse
min
sampl
buffer
acet
acid
ethanol
water
result
sampl
analyz
colorimet
molecular
devic
spectramax
signal
measur
k
nm
obtain
result
normal
control
sampl
cell
viabil
set
human
codonoptim
sequenc
encod
ectodomain
se
amino
acid
clone
deriv
express
plasmid
li
et
al
se
sequenc
preced
sequenc
encod
ntermin
signal
peptid
follow
sequenc
encod
ctermin
artifici
leucin
zipper
trimer
motif
streptag
affin
purif
iba
gmbh
describ
previous
haemagglutinin
ha
ectodomain
influenza
viru
bosch
et
al
express
cell
transfect
se
express
plasmid
use
polyethyleneimin
pei
ratio
lg
dna
lg
pei
h
incub
transfect
medium
replac
sfm
ii
express
medium
invitrogen
supplement
sodium
bicarbon
gl
glucos
gl
primaton
rluf
gl
penicillin
uml
streptomycin
lgml
glutamax
gibco
dimethyl
sulfoxid
five
six
day
posttransfect
se
protein
purifi
cultur
medium
use
streptactin
affin
chromatographi
iba
gmbh
express
purif
se
protein
confirm
western
blot
sdspage
analysi
data
shown
find
whether
htcc
interact
protein
fluoresc
spectra
htcc
label
fitc
c
fitchtcc
lgml
water
assess
control
sampl
sampl
contain
increas
concentr
bovin
serum
albumin
sigmaaldrich
measur
conduct
slmaminco
spectrofluorimet
k
ex
nm
null
hypothesi
protein
content
sampl
absorb
electromagnet
wave
excit
wavelength
interfer
readout
reject
base
obtain
result
data
shown
experi
perform
triplic
result
express
mean
sd
determin
signific
obtain
result
comparison
group
made
use
student
test
p
valu
consid
signific
paper
report
studi
antivir
properti
modifi
natur
polym
chitosan
deriv
ie
n
chitosan
chlorid
htcc
fig
htcc
hydrophob
modifi
dodecyl
group
ie
ndodecyln
chitosan
chlorid
hmhtcc
fig
polym
select
larger
librari
compound
see
supplementari
fig
polyc
sinc
contain
amin
ammonium
group
polym
select
test
sinc
cation
polym
particular
contain
ammonium
group
may
potenti
show
antimicrobi
properti
timofeeva
et
al
order
appropri
evalu
inhibitori
activ
test
polym
two
assay
employ
infect
result
consider
alter
cell
morpholog
subsequ
cell
detach
cytopath
effect
cpe
typic
occur
day
post
infect
associ
product
infecti
virion
briefli
cell
seed
plate
media
contain
increas
concentr
inhibitori
polym
cell
infect
tissu
cultur
infecti
dose
tcid
reduct
cpe
suscept
cell
infect
investig
analysi
reveal
htcc
hmhtcc
hamper
appear
morpholog
chang
cell
death
follow
infect
fig
test
polym
minim
inhibitori
concentr
ic
valu
rel
low
amount
lgml
nm
htcc
lgml
nm
hmhtcc
tabl
reduct
cpe
viral
infect
may
result
actual
inhibit
viru
entri
replic
also
cytoprotect
ie
inhibit
delay
develop
cpe
affect
viru
product
rule
possibl
quantit
rtpcr
base
assay
employ
assess
yield
cell
cultur
supernat
assay
perform
previous
describ
golda
et
al
number
rna
copi
per
millilit
cell
cultur
supernat
assess
conduct
analysi
clearli
show
presenc
studi
polym
signific
decreas
number
viral
copi
produc
infect
fig
best
result
obtain
htcc
polym
ic
valu
reach
lgml
nm
fig
tabl
though
pronounc
inhibit
note
also
hmhtcc
compound
latter
polym
appear
toxic
ic
valu
markedli
higher
lgml
nm
fig
tabl
cell
constitut
best
describ
vitro
model
allow
effect
replic
therefor
cell
use
current
studi
schildgen
et
al
test
whether
observ
effect
cellspecif
inhibitori
activ
polym
natur
environ
also
assess
hae
cultur
mimick
natur
conduct
airway
epithelium
use
purpos
hae
cultur
form
multilay
fulli
differenti
primari
human
airway
epitheli
cell
grow
collagenco
plastic
support
airliquid
interphas
banach
et
al
pyrc
et
al
due
technic
restrict
possibl
use
standard
assay
inhibitor
present
apic
medium
hae
cultur
infect
presenc
test
inhibitor
h
incub
subsequ
apic
medium
remov
apic
surfac
mockinfect
hae
cultur
rins
everi
h
medium
contain
given
inhibitor
sampl
apic
fluid
concurr
collect
realtim
rtpcr
analysi
show
drastic
decreas
number
viral
copi
presenc
test
polym
prove
effect
also
seminatur
set
fig
also
note
incub
hae
cul
fig
structur
polym
show
anticoronavir
properti
nativ
chitosan
amino
group
partial
deacetyl
mean
glucos
group
may
substitut
nh
ch
conhgroup
macromolecul
sinc
distribut
acetyl
deacetyl
nh
group
along
chitosan
chain
random
often
reflect
show
r
may
either
h
coch
group
consequ
sinc
hmhtcc
polym
nh
group
substitut
c
h
group
r
group
may
h
coch
group
c
h
group
chitosan
chain
therefor
hmhtcc
r
may
h
coch
c
h
ture
respect
polym
result
mark
decreas
cell
viabil
fig
suggest
polym
may
potenti
use
treatment
coronavir
ill
order
test
whether
investig
compound
select
inhibit
replic
show
broader
anticoronavir
activ
similar
assay
perform
mhv
viru
briefli
mhv
infect
result
massiv
cell
death
within
h
post
infect
cpe
occurr
h
postinfect
score
plate
media
contain
inhibitori
polym
cell
infect
mhv
tissu
cultur
infecti
dose
tcid
reduct
cpe
suscept
cell
infect
mhv
investig
analysi
reveal
htcc
hmhtcc
hamper
appear
morpholog
chang
cell
death
follow
infect
present
fig
quantit
rtpcr
base
assay
employ
assess
mhv
yield
cell
cultur
supernat
assay
perform
describ
section
number
rna
copi
per
millilit
cell
cultur
supernat
assess
obtain
result
confirm
observ
shown
fig
prove
presenc
htcc
hmhtcc
mhv
replic
limit
log
compar
control
sampl
fig
b
hmhtcc
cytotox
may
observ
highest
concentr
test
lgml
toxic
mark
toxic
observ
htcc
compound
lower
toxic
compar
cell
like
result
shorter
incub
time
mhv
h
instead
h
subsequ
effort
made
determin
whether
test
compound
abl
inhibit
replic
human
virus
appropri
studi
subject
varieti
viral
speci
test
includ
human
metapneumoviru
human
adenoviru
human
echoviru
influenza
viru
human
herpesviru
type
analysi
conduct
cpe
assess
inhibit
virusmedi
effect
observ
data
shown
cytotox
test
polym
assess
cell
suscept
infect
cell
suscept
mhv
infect
cell
experi
aim
determin
cytotox
test
compound
conduct
ident
condit
use
assess
antivir
potenti
polym
ie
cell
incub
day
cell
incub
h
presenc
inhibitori
compound
two
differ
assay
use
appropri
evalu
cytotox
potenti
test
polym
first
xtt
test
perform
base
abil
eukaryot
mitochondri
enzym
transform
substrat
color
formazan
salt
direct
relationship
cell
viabil
amount
dye
produc
possibl
determin
rel
viabil
cell
neutral
red
nr
assay
use
second
method
neutral
red
dye
abl
penetr
live
cell
accumul
endosom
therefor
possibl
analyz
quantifi
rate
process
describ
section
follow
incub
cell
presenc
test
polym
media
remov
cell
viabil
evalu
method
produc
consist
estim
polym
toxic
result
present
tabl
fig
htcc
polym
toxic
effect
concentr
lgml
show
highli
specif
inhibit
viral
infect
higher
concentr
cytotox
effect
becom
visibl
ic
lgml
one
rememb
cell
incub
polym
six
consecut
day
due
low
replic
rate
model
system
second
test
polym
hmhtcc
show
similar
toxic
though
inhibitori
properti
inferior
compar
htcc
cell
follow
incub
presenc
test
polym
media
remov
cell
viabil
evalu
xtt
assay
fig
obtain
result
consist
present
fig
also
case
cytotox
observ
effect
rang
htcc
minor
toxic
hmhtcc
cytotox
polym
also
test
fulli
differenti
human
airway
epithelium
hae
fig
signific
cytotox
observ
xtt
assay
day
incub
visibl
alter
hae
cultur
integr
ciliat
observ
lack
cytotox
may
easili
explain
case
cell
expos
polym
throughout
whole
time
apic
surfac
hae
cultur
rins
everi
h
medium
contain
given
polym
incub
time
shorter
cell
h
one
may
assum
test
polym
inhibit
replic
earli
phase
infect
inhibit
note
compound
provid
initi
virion
adher
phase
data
shown
order
elucid
mechan
htcc
action
interact
htcc
protein
evalu
purpos
htcc
substitut
fitc
fluoresc
emiss
intens
presenc
increas
concentr
measur
present
fig
fluoresc
intens
diminish
presenc
concentrationdepend
manner
observ
indic
strong
interact
test
biopolym
result
signal
quench
complex
format
decreas
fluoresc
intens
fitchtcc
observ
presenc
bovin
serum
albumin
bsa
indic
bsa
interact
fitchtcc
consequ
specif
interact
htcc
human
coronavirus
receiv
rel
littl
attent
human
pathogen
year
consid
common
cold
virus
sarscov
epidem
subsequ
studi
famili
pathogen
reveal
surpris
varieti
speci
infect
anim
human
potenti
futur
coronavirusrel
outbreak
van
der
hoek
et
al
woo
et
al
woo
et
al
particularli
import
consid
recent
identif
new
coronaviru
infect
human
wise
mention
clear
link
respiratori
diseas
establish
prospect
populationbas
studi
pride
lower
respiratori
tract
infect
children
less
three
year
age
germani
children
infect
laryngotrach
croup
compar
control
group
multivari
analysi
demonstr
chanc
croup
time
higher
children
children
van
der
hoek
et
al
consid
observ
pathogen
worldwid
distribut
viru
sever
case
eg
children
immunocompromis
elder
patient
applic
therapeut
drug
may
requir
hamper
diseas
progress
present
inhibitor
describ
interf
differ
stage
replic
uniqu
mechan
coronavir
replic
includ
posttransl
process
larg
polyprotein
carri
highli
conserv
specif
viral
proteas
seem
promis
target
therapi
yang
et
al
design
synthes
set
specif
pro
inhibitor
repress
replic
multipl
coronavirus
includ
yang
et
al
anoth
interest
approach
propos
pyrc
et
al
use
synthet
peptid
interf
protein
fusogen
activ
interact
heptad
repeat
region
domain
group
author
suggest
employ
rnai
technolog
small
molecul
inhibitor
previous
shown
inhibit
virus
interest
novel
approach
inhibit
coronavir
infect
propos
initi
pfefferl
et
al
identifi
interact
cyclophilinsimmunophilin
coronavir
nonstructur
protein
interact
maintain
coronavir
speci
though
even
import
commerci
avail
peptid
inhibitor
cyclophilinsimmunophilin
abl
hamper
coronavir
infect
carbajolozoya
et
al
de
wild
et
al
pfefferl
et
al
tanaka
et
al
current
studi
number
polym
test
potenti
antivir
activ
includ
n
chitosan
chlorid
htcc
ndodecyln
chitosan
chlorid
hmhtcc
poli
vinyl
alcohol
chlorid
htpva
poli
allylamin
hydrochlorid
pah
n
dextran
chlorid
low
molecular
weight
chitosan
protamin
sulfat
hydroxypropylcellulos
graft
poli
vinylamin
iotaand
kappacarrageenan
heparin
copolym
thymylethyl
acryl
tea
methacryloyl
aminopropyltrimethylammonium
chlorid
maptac
see
supplementari
fig
detail
polym
abl
imped
replic
viru
vitro
name
htcc
hydrophob
deriv
hmhtcc
select
htpva
pah
show
low
inhibitori
activ
studi
show
polym
also
abl
inhibit
replic
mhv
cell
cultur
evalu
compound
use
human
virus
ie
influenza
hmpv
adenovirus
enterovirus
human
herp
viru
type
show
inhibitori
activ
suggest
abolish
coronavir
infect
highli
specif
process
exact
mechan
antivir
activ
select
compound
remain
elucid
though
size
charg
polym
suggest
activ
transport
cell
therefor
one
may
assum
observ
activ
reli
direct
interact
polym
viru
eg
protein
essenti
viru
entri
inde
analysi
interact
htcc
polym
recombin
ectodomain
protein
show
bind
result
format
proteinpolym
complex
one
may
assum
bind
result
effici
inactiv
viru
unfortun
possibl
determin
whether
htcc
polym
hamper
interact
affin
low
lin
et
al
mathewson
et
al
possibl
visual
process
access
method
care
analysi
polym
suggest
combin
particular
polymer
chain
proper
substitu
indispens
activ
exampl
nonmodifi
oligochitosan
present
antivir
properti
furthermor
inhibitori
effect
seen
polymer
chain
substitut
similar
fashion
data
shown
fluoresc
spectra
fitchtcc
presenc
lgml
sequenc
chang
spectra
increas
concentr
given
arrow
au
arbitrari
unit
b
concentrationdepend
decreas
rel
fluoresc
intens
ii
fitchtcc
k
nm
presenc
concentr
k
ex
nm
c
fitchtcc
lgml
j
analog
measur
fitchtcc
spectra
presenc
bovin
serum
albumin
bsa
perform
control
assay
perform
triplic
repres
spectra
present
fig
averag
valu
fluoresc
intens
band
maximum
standard
error
error
bar
fig
evalu
polym
effici
inhibit
viral
replic
thu
one
may
consid
potenti
new
class
anticoronavir
agent
futur
use
treatment
acut
respiratori
ill
children
immunocompromis
patient
one
may
also
specul
due
mucos
local
infect
mechan
inhibit
polym
may
deliv
form
aerosol
directli
site
infect
furthermor
htcc
hmhtcc
polym
show
antimhv
activ
suggest
develop
compound
may
serv
anticoronavir
drug
addit
studi
requir
synthes
deriv
select
polym
would
show
better
pharmacokinet
profil
lower
cytotox
